In short
Podcast Summary: Bloomberg Intelligence - Estée Lauder in Talks to Buy Puig to Create Beauty Giant
Episode Overview In this episode of Bloomberg Intelligence, hosts Paul Sweeney and Scarlet Fu delve into various investment topics, with a major focus on Estée Lauder's potential acquisition of Puig Brands, which would create a cosmetics giant boasting approximately $20 billion in annual sales. The episode also covers discussions on the auto industry, Nexstar's acquisition of Tegna, and updates from the biotech sector.
Key Discussions
Estée Lauder's Potential Acquisition of Puig
- Guest: Clara Hernanz Lizarraga, Bloomberg Companies Reporter
- Estée Lauder is reportedly in talks to purchase Puig Brands, a move that would significantly enhance its fragrance portfolio.
- Puig Brands Overview:
- Primarily known for fragrance brands like Carolina Herrera, Jean Paul Gaultier, and Rabanne.
- This acquisition could increase Estée Lauder's fragrance revenue, which currently accounts for about 17% of its total revenue.
- The deal would expand Estée Lauder's market presence, especially in Europe and Latin America, allowing for more effective competition against rivals such as L'Oréal.
- Strategic Fit:
- Estée Lauder is currently focused on streamlining operations and enhancing its luxury fragrance offerings, raising questions about the timing and strategic fit of this acquisition.
- Concerns were raised regarding the shareholder reaction, as Estée Lauder's shares have seen a decline amidst these discussions.
- Family Dynamics:
- Puig is family-owned, with the CEO relinquishing operational control to prepare for succession. This raises questions about whether the family would be willing to sell the company.
U.S. Auto Industry Outlook
- Guest: Steve Man, Global Autos and Industrials Research Analyst
- The ongoing geopolitical tensions and economic conditions are expected to put pressure on the auto industry, potentially leading to a 15% drop in auto sales.
- High oil prices are influencing consumer behavior, shifting preferences toward hybrids and electric vehicles (EVs).
- Current Trends:
- Rising interest rates make auto loans more expensive, prompting consumers to hold on to their vehicles longer or opt for secondhand cars.
- Automakers like Toyota, Tesla, and Rivian could benefit from the growing shift towards hybrids and EVs in an environment of high fuel prices.
Nexstar's Tegna Acquisition and Legal Challenges
- Guest: Jennifer Rie, Senior Litigation Analyst
- Nexstar recently completed its acquisition of Tegna, previously cleared by the FCC and DOJ.
- Despite regulatory approval, legal challenges from eight states and DirecTV could pose risks to the acquisition's legitimacy.
- State Actions:
- States are increasingly taking up the mantle of antitrust enforcement, suggesting that federal regulators may not be stringent enough in their merger approvals.
Biotech Sector Insights
- Guest: Sam Fazeli, Director of Research for Global Industries and Senior Pharmaceuticals Analyst
- Pfizer's experimental Lyme disease vaccine showed only 73% efficacy, which raises questions about its market viability against pre-existing vaccines.
- The discussion highlighted the ongoing public health concerns surrounding Lyme disease and the need for effective vaccines.
Key Takeaways
- The proposed acquisition of Puig by Estée Lauder represents a strategic move to strengthen its market position in the fragrance sector amidst ongoing operational restructuring.
- The auto industry is facing potential declines in sales amid rising oil prices and economic uncertainties, with a noticeable shift towards electric and hybrid vehicles.
- Legal challenges to Nexstar's acquisition of Tegna underscore the evolving landscape of antitrust enforcement, with states stepping in where federal regulators may be perceived as lenient.
- In the biotech field, the efficacy of Pfizer's Lyme disease vaccine prompts critical evaluation of public health strategies and vaccine development.
Conclusion This episode of Bloomberg Intelligence provides a thorough analysis of significant industry movements, showcasing the interplay between corporate strategy, market dynamics, and regulatory landscapes in the current investment climate.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Chapters
Tap a time to open that second in VOEstée Lauder's Acquisition Talks
2:24 to 3:28
Discussion on Estée Lauder's potential acquisition of Puig Brands.
“She is company's reporter for Bloomberg News.”
Puig Brands Overview
3:28 to 4:38
Insights into Puig Brands and its market impact on fragrances.
“It's got this plan to focus on niche luxury priced fragrances.”
Strategic Fit for Estée Lauder
4:38 to 5:44
Exploring whether the acquisition aligns with Estée Lauder's strategy.
“So the family owns most of the capital and over 90 % of their voting rights.”
Concerns and Family Dynamics
5:44 to 7:12
Discussion on family control in Puig and potential acquisition challenges.
“But the thing about Pooj is that it also operates, as you mentioned, Carolina Herrera, Nina Ricci.”
Regulatory Considerations
7:12 to 8:12
Exploring potential regulatory issues with Estée Lauder's acquisition.
“There's some concerns on the makeup side.”
Nexstar and Tegna Deal Analysis
15:05 to 19:22
Deep dive into the regulatory landscape around the Nexstar-Tegna acquisition.
“And from what I understand, that's turning out to be the truth.”
States Challenging Federal Approvals
19:22 to 23:11
Discussion on states' lawsuits against federal approvals of mergers and acquisitions.
“And that rule today, having done a million broadcasting M &A deals in my life, seems so antiquated.”
The Lyme Disease Vaccine Development
23:11 to 26:05
Exploration of the developments in Lyme disease vaccine research by Pfizer.
“working on a Lyme disease drug here, and they recently had, I think they had a study that didn't really impress too much, but I'll tell you, in this part of the country, Lyme disease is no joke.”
Impact of Funding on Medical Research
26:05 to 27:56
Explores how changes in funding affect university medical research programs.
“But again, if you took this, you're only three quarters of the way, let's say, protected.”
Transcript
Automatic transcript. May contain errors.0:00Scarlet Fu:Small businesses are the pulse of every community. They bring people together, create opportunities, and drive growth. Chase for Business helps business owners like you with personalized guidance and convenient digital tools all in one place. With that guidance and your determination, you can take your business farther and help build a brighter future for your community. Learn more at chase.com slash business. Chase for Business. Make more of what's yours. The Chase mobile app is available for select mobile devices. Message and data rates may apply. JPMorgan Chase Bank, NA. Member FDIC. Copyright 2026.
0:34Scarlet Fu:JPMorgan Chase and Company. So there's a lot of noise about AI, but time's too tight for more promises. So let's talk about results. At IBM, we work with our employees to integrate technology right into the systems they need. Now, a global workforce of 300 ,000 can use AI to fill their HR questions, resolving 94 % of common questions. Not noise. Proof of how we can help companies get smarter by putting AI where it actually pays off, deep in the work that moves the business. Let's create smarter business. IBM. Find home wherever you roam at Sonesta ES and Simply Suites, where longer stays feel comfortable, flexible, and easy.
1:14Stretch out and enjoy spacious accommodations and home-like amenities designed to help you settle in and stay productive or relaxed for however long you need. And when you're a Sonesta Travel Pass member, staying at Sonesta ES and Simply Suites means earning points toward free nights, upgrades, and more with every eligible stay. Go to Sonesta.com to book your stay and unlock the best rates with Sonesta Travel Pass. Here today, roam tomorrow. Join now at Sonesta.com. Terms and conditions apply.
1:46Scarlet Fu:Bloomberg Audio Studios. Podcasts. Radio. News. You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App. Listen on demand wherever you get your podcasts or watch us live on YouTube. Kind of a merger Tuesday, if you will. Estee Lauder Companies is in talk to buy Pooj Brands in a deal that would create a cosmetic giant with about$20 billion in annual sales here. Let's get some more details on this transaction. We're joined by Clara Lizaraga. She is company's reporter for Bloomberg News. She is based in Madrid.
2:29Clara, tell us a little bit about Pooj brands. Who are they and why do you think Estee Lauder is in talks to acquire them? hi paul thank you for having me so um pooch unlike estee lauder gets most of its revenues from fragrances it owns major brands like carolina herrera robin john paul gotti and these are brands that have products that have consistently been amongst the top 10 best-selling fragrances so for estee lauder it would help strengthen their position in this category of fragrances where they currently get about 17 % of their revenues. And as you said, it would create a much larger company with a stronger exposure to Europe and Latin America and help it compete more efficiently against rivals like L 'Oreal, for example.
3:22Scarlet Fu:So Clara, I guess the thing with Estee Lauder is that this is a company in reorganization mode. It's got this plan to focus on niche luxury priced fragrances. Does buying Pooch fit into that very specific strategy? Well, exactly. So these are some of the questions that have been asked today. So whether this is the right time for Estée L 'Odère because they're in the middle of streamlining operations. They were at some point reviewing underperforming brands to see if they could divest from some of them. and focusing on higher and more profitable products. So there are questions about whether a deal with Pugna would, one, be the right fit and also would be the right timing, considering these other complex problems need to be resolved.
4:14The reaction so far, so Estee Lodez shares have been falling yesterday and again today. So it would seem that these concerns are definitely weighing in. And Pusch is a family-owned, I know the CEO, Mark Pusch, a member of the founding family, did give up that role, but he is executive chairman. What role does the family play in this company? So the family owns most of the capital and over 90 % of their voting rights. Okay. This is the third generation of the family. And part of the reasons behind the IPO that happened less than two years ago was that they wanted to plan succession and prevent any tensions that could arise relating to generational change by listing the company and making sure that the, you know, the future generations would be owners of the company.
5:18but not necessarily in operational roles. So in that sense, a deal could go in further in that direction. But it also is surprising to think that the family would relinquish control over this company, which is over 100 years old.
5:36Scarlet Fu:Yeah, there's so many things to have to kind of reconcile here. We talked about how Estee Lauder would want to add to its fragrance line to widen that portfolio. But the thing about Pooj is that it also operates, as you mentioned, Carolina Herrera, Nina Ricci. These are all fashion brands. They present collections during the Paris Fashion Week. Is that something S.A. Lauder wants to get into? Or is that something that S.A. Lauder might, I don't know, divest? Or would that be part of the acquisition? um i i think it would because so in essence the pooch strategy has been to buy brands they they make fashion but they also create this image around the the brand and then thanks to that they sell the fragrances so it sort of goes together and it's hard to separate the fashion from the fragrances i think in that sense it would be complementary to estee lauder i guess the question is Pooj also has a smaller part of the business that's called niche brands so things like Byredo another one called L 'Artisan Parfumur and these are much smaller brands with higher prices that the company's been wanting to scale but they currently account for roughly 10 to 15 percent of revenues according to analysts so that's something that would be interesting to Estee Lauder, but there are questions about really how much can that grow and, well, would they want all of these kinds of fragrances or only certain brands?
7:06Is there any regulatory concern here about this deal getting approved? There's some concerns on the makeup side. So Poo Jones Charlotte Tilbury, which I believe is the third largest makeup brand in the US. And so there could be issues on that front, but on the fragrant grounds front, I think it's not a problem. Stay with us. More from Bloomberg Intelligence coming up after this. For many men, mental health challenges aren't recognized until they've already taken a toll. Work pressure, financial stress, changing relationships, and traditional expectations around masculinity can quietly wear men down, often without clear warning signs.
7:50In Season 3 of The Visibility Gap, Dr. Guy Winch and his guests explore how these pressures show up, how to spot them earlier, and how men can access meaningful support. Listen to the new season of The Visibility Gap, a podcast presented by Cigna Healthcare.
8:06Scarlet Fu:You need to make a huge presentation in an hour. Adobe Acrobat uses AI to take all your documents and generate a presentation with a single click. Build slides quickly and streamline the process. Need a last-minute pitch deck? Do that with Acrobat. Need to level up your presentation design? Do that with Acrobat. You have 30-plus documents that need to be simplified into a proposal. Do that. Do that. Do that with Acrobat. Learn more at adobe.com slash do that with Acrobat.
8:43With Bali from iShares, you get access to both monthly income and growth potential in one simple ETF. It's the best of both worlds. Discover Bali. iShares large cap premium income active ETF. iShares. The market is yours. Visit www.iShares.com to view perspectives for investment objectives, risks, fees, expenses, and other information that you should read and consider carefully before investing. Risks include principal loss and the use of derivatives, which could increase risks and volatility. Monthly income is not guaranteed. Prepare by BlackRock Investments, LLC.
9:11Scarlet Fu:You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App. Listen on demand wherever you get your podcasts or watch us live on YouTube. One of the things that the Bloomberg Intelligence folks are looking at is gaming out a recession scenario that may be a little bit more on the front burner now with what's happening in Iran. And one of those industries that you really have to be on the outlook for should the economy soften is the U.S. auto business. And Steve Mann joins us here, Global Autos and Industrials Research Annals for Bloomberg Intelligence, joining us live here in our Bloomberg Interactive Broker Studio.
9:48So, Steve, I mean, the auto business, I mean, cyclical business, but also one that's undergoing a profound transformation, trying to make this transformation to electric vehicles. Probably not a lot of spare capital lining around the cushion during if the economy were to soften. How do you guys think about it? Well, yeah, the industry did take a lot of write-offs because, you know, the EV sales are not going to be what it expected, especially in the U.S. And we were actually coming into 2026 relatively positive for the Detroit Big Three because Trump eliminated, you know, the penalties on gas guzzlers.
10:29We thought, you know, they're going to, you know, these automakers are going to push out these, you know, pickup trucks, SUVs with high margins. And that's how we came in looking at the industry at the beginning of 2026. But then the war broke out, right? And gas prices are at where they're at. If you talk to the people that actually buy and sell gas, oil, it's like 150 bucks, right, on the ground. So it's having a huge impact. Gasoline prices are up 30%, 40 % where I'm at. So now the talk is, you know, are they going to sell that many? pickup trucks and SUVs. Yeah.
11:09Scarlet Fu:Especially with interest rates rising, that means auto loans also become more expensive for consumers. But people will still need cars and they will still need to upgrade or replace their aging vehicles. Where does that leave the automakers? I mean, do people go to secondhand cars? Do they take another look at hybrids and EVs in this environment? I think it's a combination of both. The third thing that could happen is they keep their cars a little bit longer. You know, that's going to benefit companies like O 'Reilly, AutoZone, that actually sells aftermarket parts. You know, a lot of consumers, especially in this K economy, those who are looking for value in affordable vehicles will hold off, you know, even if interest rates are lower.
11:56You know, they want to make sure, you know, the jobs are stable and before they spend$20 ,000,$30 ,000,$40 ,000. dollars how much is a new car again on average average is 50 000 yeah and i'll tell you my boy joe uh in his used car his car repair shop in manisquan his lot is packed man i mean he's got more business he knows what to do with so that goes to your point yeah people are keeping their cars longer you know if we get higher for longer fuel prices does that revive maybe some demand in in EVs and the hybrids? It might. Look, we actually looked at, figured out, looked at what the worst case scenario is.
12:36We looked at past oil shock all the way back to, you know, the Iranian revolution back in the 70s. And we're coming up with, okay, worst case sales in the US could drop as much as 15%. Now, the pie is shrinking, but even within that pie, the split is changing. Definitely. I think it's no surprise. If oil prices are high, it has happened in the past, people will be more interested in hybrids. And this time around, battery EVs as well.
13:10Scarlet Fu:Stay with us. More from Bloomberg Intelligence coming up after this. For many men, mental health challenges aren't recognized until they've already taken a toll. Work pressure, financial stress, changing relationships, and traditional expectations around masculinity can quietly wear men down, often without clear warning signs. In Season 3 of The Visibility Gap, Dr. Guy Winch and his guests explore how these pressures show up, how to spot them earlier, and how men can access meaningful support. Listen to the new season of The Visibility Gap, a podcast presented by Cigna Healthcare. Everyone has been there.
13:47Scarlet Fu:Your team's feedback is scattered across emails, chats, and sticky notes. It's a mess. But PDF Spaces and Adobe Acrobat gives you one collaborative workspace to streamline every file and comment. So, if you need six departments to finally agree on a proposal, do that with Acrobat. Need to turn a mountain of feedback into one plan of action? Do that with Acrobat. Want to stop searching for files and finally get everyone on the same page? Do that, do that, do that with Acrobat. Learn more at adobe.com slash do that with Acrobat.
14:52We'll see you next time.
14:54Scarlet Fu:you're listening to the bloomberg intelligence podcast catch us live weekdays at 10 a.m eastern on apple carplay and android auto with the bloomberg business app listen on demand wherever you get your podcasts or watch us live on youtube one of the issues from an m a perspective with the second trump administration is this is going to be a very good time to get m a done the regulation the regulators whether it be the federal trade commission department of justice just maybe be more accommodative. And that was certainly the expectation. And from what I understand, that's turning out to be the truth.
15:29And we want to focus on one particular deal, because it's a deal that I'm very familiar with, having covered the media industry for a while. And that is Nexstar, big TV station owner, buying Tegna, another big TV station owner. Jennifer Reed joins us. She's senior litigation analyst for Bloomberg Intelligence, joining us live here in our studio. So as I understand it, Nexstar, again, Again, a huge owner of TV stations across the country, hundreds of them, closed its purchase of Tegna, which are the old TV stations owned by Gannett Company, the newspaper company. That closed. Yes. From the regulators.
16:02Like the Federal Communication Commission, the Justice Department blessed the deal as people thought they would. That's right. That's this administration. But there's still some suits going on. What's going on with that?
16:12Scarlet Fu:Right. Right. So that expectation that the Department of Justice and Federal Communications Commission would go ahead and allow that deal to go forward, I think, ramped up a group of states to be ready to try to go after this deal. And it's because the states have been saying, many states have been saying, and not just Democratic state attorneys general, but in a bipartisan way, the states have been saying, if this administration lacks antitrust enforcement, if they start allowing a lot of consolidation across many industries, we're going to pick up the slack. because states have the right to enforce federal antitrust laws, and they have the right to go after a merger that they believe is unlawful under the antitrust laws, just as the Department of Justice or Federal Trade Commission do.
16:52Scarlet Fu:So that's what we're seeing here. You have eight states that have said this wasn't right. For different reasons, the FCC approval was improper for certain reasons. The Department of Justice clearance was improper for other reasons, and we're going to go ahead and go to court to try to see what we can do here. I've been doing this media M &A thing for a long time. I've never really seen this before. I'm sure it's been out there. So this is basically the state saying, for whatever reason, the federal government, from our perspective, from our point of view, is not as strong a regulator as it needs to be.
17:27Therefore, we're going to pick up the slack and do it from a state level.
17:29Scarlet Fu:Yes. Have we seen this before? Not a lot. Okay. Normally, the states are sort of aligned with the Department of Justice or any of these agencies that are reviewing a deal. We have one example from several years ago when T-Mobile and Sprint merged. They settled with the Department of Justice. They divested some assets to DISH, and the Department of Justice went ahead and cleared the deal. The FCC cleared the deal, and the states went to court. A group of states, I don't remember exactly how many, I think it might have been around 10, went to court to try to block that deal. And, you know, a lot of people would say, and I'll say in this case, too, for Nextar, that once you have the federal regulators that have approved these deals, it is very difficult for the states to then go into court and convince a judge that the experts that cleared the deal were wrong.
18:10Scarlet Fu:The states lost in the T-Mobile Sprint effort. And, you know, we don't know yet what's going to happen with Nexstar. But they do go in with a tough case to make once the FCC and DOJ have approved, which they have. So are they doing this, these states? And you say it's bipartisan, so it's not just Democratic states that maybe wanted to just go against this administration's regulatory policy. I think in this case, it may simply be Democratic states, the ones that have sued Nextar. We also have states that are continuing litigation against Live Nation that originally the Department of Justice had joined them with, was the lead plaintiff.
18:46Scarlet Fu:The Department of Justice settled with one week of trial. The states, in a bipartisan way, have gone forward to continue that litigation. So we are seeing bipartisan efforts in that area. with the next star tegna i'd have to look at those eight states to see the attorney generals right whether they are democrats or republicans if you're next star you close this deal you you pay tegna the money yes is there any risk to next star that somebody some judge could say you got to unwind this thing i think that risk is low i think actually getting an order saying you must unwind this is low if there's some kind of a liability decision yet this deal was anti-competitive My guess would be the more likely outcome would be some divestitures of stations, which is honestly what I thought would have happened with this deal with the Department of Justice to start if it had followed kind of its longstanding tradition with respect to TV broadcaster deals.
19:39Scarlet Fu:Usually the Department of Justice would ask these companies, including Nexstar, which has divested all sorts of stations doing deals in the past to divest in a local area called a DMA in this case, to divest if they would own more than one of the local affiliates of the big four, which are NBC, CBS, Fox, ABC. And that rule today, having done a million broadcasting M &A deals in my life, seems so antiquated. It was antiquated 20 years ago. But now with all the streaming and I mean, it's like, who cares? Well, that's the argument the defendants will make. And that's what the Federal Communications Commission said, in part, in approving this deal.
20:15Scarlet Fu:But I will say that there was an Eighth Circuit decision about the FCC's, every four years it reviews its rules, about its review of its rules. And that narrow market definition focused on those broadcast stations in the Big Four was challenged. And the Eighth Circuit didn't reject that. They rejected rules changes for different reasons, but not because of that market definition. And the thing is, Paul, I know viewership has changed radically, right? In the last 10, 20 years, you've got all the cord cutters, you have people who've never even heard of a cable subscription, but you still have a set of consumers that get those cable subscriptions or Fios or whatever it is.
20:53Scarlet Fu:They want those local stations. They want sports. They want the local programming they can get. And if you have a discrete set of consumers that could be harmed because prices go up, it can still be an antitrust harm. Stay with us. More from Bloomberg Intelligence coming up after this. For many men, mental health challenges aren't recognized until they've already taken a toll. Work pressure, financial stress, changing relationships, and traditional expectations around masculinity can quietly wear men down, often without clear warning signs. In Season 3 of The Visibility Gap, Dr. Guy Winch and his guests explore how these pressures show up, how to spot them earlier, and how men can access meaningful support.
21:31Listen to the new season of The Visibility Gap, a podcast presented by Cigna Healthcare.
21:39Scarlet Fu:Everyone has been there. Your team's feedback is scattered across emails, chats, and sticky notes. It's a mess. But PDF Spaces and Adobe Acrobat gives you one collaborative workspace to streamline every file and comment. So, if you need six departments to finally agree on a proposal, do that with Acrobat. Need to turn a mountain of feedback into one plan of action? Do that with Acrobat. Want to stop searching for files and finally get everyone on the same page? Do that, do that, do that with Acrobat. Learn more at adobe.com slash do that with Acrobat.
22:20With Bali from iShares, you get access to both monthly income and growth potential in one simple ETF. It's the best of both worlds. Discover Bali, iShares large cap premium income active ETF. iShares, the market is yours. Visit www.iShares.com to view perspectives for investment objectives, risks, fees, expenses, and other information that you should read and consider carefully before investing. Risks include principal loss and the use of derivatives, which could increase risks and volatility. Monthly income is not guaranteed. Prepared by BlackRock Investments, LLC.
22:48Scarlet Fu:You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App. Listen on demand wherever you get your podcasts or watch us live on YouTube. Switch gears. We'll go to healthcare as we like to do. There's always news coming out of the healthcare business. There's always M &A trades, and this is no different. Pfizer, they've been working on a Lyme disease drug here, and they recently had, I think they had a study that didn't really impress too much, but I'll tell you, in this part of the country, Lyme disease is no joke.
23:23Boy, a lot of people get it, and it's bad. Debilitating.
23:26Scarlet Fu:Yeah, and it affects you for life, Even if you get over the worst of it in the first two years. So there's just another area where you're kind of waiting for the great science of the pharmaceutical and biotech industry to come to the rescue. Sam Fazelli joins us, Bloomberg Intelligence Director of Research for Global Industries and a senior pharma analyst for Bloomberg. So, Sam, what's going on with Pfizer? What's going on broadly with this little niche field of Lyme disease? Lyme disease, Paul. So all those farmers and folks who go out into fields have a risk of that. Of course, anyone who goes out into a green space, I've got a bit of a garden.
Read the full transcript
24:04I'm sure you do. And those ticks, man, they do like your legs and anything that's nice and hidden in there to go and have a bite at. And all your animals suffer from it, et cetera. So those animals can take drugs to prevent ticks. But there's really no such thing for humans. And I mean, vaccines have been around, but Lyme disease vaccine is something that would really be quite an attractive option for those who are at risk. The question is, who would take a Lyme disease vaccine? But these guys had some data. It's data from a vaccine that they're developing with a French partner called Valneva.
24:39It's been in development for a while. And I'm just reading the details here again off the screen on the Bloomberg terminal. 73 % effective against the tick-borne illness, which of course can be as bad as encephalitis and causing major then longer-term issues. So the problem is 73%. I mean, you know, is that good enough these days? I mean, think about COVID. COVID vaccines now on a background of people having lots of COVID infections are in the 50 to 60 to 70 percent range effective against hospitalization. Now, that's on the background of lots of COVID infections. Here, you're testing it literally against somebody having no immunity.
25:22So 70 percent is not particularly high. So it'd be very interesting to see what the regulators say about this.
25:28Scarlet Fu:Sam, I'm kind of confused. Why are there no current human vaccines for Lyme disease on the market? I mean, there was something, I believe, back in the late 1990s from GSK, But this seems like something that there's a real demand for. Efficacy. We need efficacy. We need the effectiveness. Sorry. In vaccine world, I've forgotten now, all those years of writing about COVID. You need vaccine effectiveness, which is how much does it protect you? How long does it protect you for? So this is something that I think would be interesting to see whether this result is better than what folks have been used to.
26:05But again, if you took this, you're only three quarters of the way, let's say, protected. And I'd like to see the data. How long does it last? Do you need another shot? Who takes this? I mean, do we want everybody? I mean, people are hardly taking infectious disease vaccines where they can pick it up in the subway. Are they going to worry about this? Take this. Those are questions, right? Hey, Sam, the beginning of President Trump's second term, there are really a lot of threats towards universities and maybe some of their medical research. Has that, in fact, come to fruition? Are funds being withheld?
26:42Are funds being pulled? Is that impacting university research? There has been some more uncertainty created, funds not being released. There's been a lot of those situations arising. Of course, it's not just grants going to universities. It's also direct investments, for instance, by the NIH, which has a huge budget. NIH gives out grants, but they also have research institutes, the Institute for this and the Institute for that. So there has been some effects. People are worried. The number of people seeking to do PhDs in the STEM world has declined. I don't know what the latest statistic is, but it's definitely declined.
27:22And that's really not helpful because it is this foundation of science that then builds the future innovations, right? I don't think that's rocket science, right? So I don't know why this became such a big thing. But I'm wondering whether it was just noise and it was playing to the public and it's kind of eventually going to dissipate and go back to what it normally was. And, of course, Congress needs to get in there. You've seen, for instance, courts coming back saying what the HHS has done isn't right for vaccines, etc. So maybe this will happen here, too.
27:56Scarlet Fu:This is the Bloomberg Intelligence Podcast, available on Apple, Spotify and anywhere else you get your podcasts. Listen live each weekday, 10 a.m. to noon Eastern on Bloomberg.com, the iHeartRadio app, TuneIn and the Bloomberg Business app. You can also watch us live every weekday on YouTube and always on the Bloomberg Terminal.
28:21Here's a paradox. We buy insurance for peace of mind, yet the very policies we trust can deliver the biggest financial shocks. Across America, millions of claims are denied every year, not because people did anything wrong, but because policies quietly excluded the things that happened. The psychology of trust tells us we assume the contract is fair, but in insurance, the information gap is massive. The insurer knows every detail of what's covered. The policyholder rarely does. That's where My Policy Advocate comes in. For just 27 cents a day, their platform reads your policies and shows you, in plain language, where you're vulnerable.
28:57They're not selling insurance. They don't do that. It's about transparency, giving ordinary people the same understanding insurance companies have had for decades. because when you know what's really in your policy, you can plan, protect, and avoid surprises. Before you trust your policy to protect you, let My Policy Advocate tell you what it really says. Visit MyPolicyAdvocate.com today. Peace of mind starts with knowing the truth. MyPolicyAdvocate.com This podcast is brought to you by WISE, the smarter way to manage your money internationally. If you're getting a headache from juggling different currencies and different bank accounts in different countries, there's a better way to receive money in the currency you need without the slow transfer times or hidden fees meet wise the savvy way to handle your money internationally hold balances in up to 40 currencies with the mid-market exchange rate on every conversion whether you're receiving payments from tenants abroad earning as a digital nomad or converting dividends from your international investments the wise multi-currency account is for you be smart get wise download the WISE app today or visit WISE.com.
30:00Terms and conditions apply.
30:27which could increase risks and volatility. Monthly income is not guaranteed. Prepared by BlackRock Investments, LLC.
From the publisher
Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu
-Clara Hernanz Lizarraga, Bloomberg Companies Reporter, discusses Estée Lauder being in talks to buy Puig Brands, which would create a cosmetics giant with about $20 billion in annual sales. A takeover of Puig would give Estée Lauder well-known perfume and fashion brands such as Rabanne, Jean Paul Gaultier and Carolina Herrera.
-Steve Man, Bloomberg Intelligence Global Autos and Industrials Research Analyst, discusses why a prolonged war with recession threatens a 15% drop in auto sales. According to Bloomberg Intelligence: a sustained spike in Brent crude oil above $100 a barrel favors automakers like Toyota, Tesla and Rivian due to their many hybrids and affordable battery electric vehicles.
-Jennifer Rie, Bloomberg Intelligence Senior Litigation Analyst, discusses Bloomberg Intelligence research on why Nexstar’s Tegna acquisition appears to be at risk of legal pause. Nexstar closed its purchase of Tegna on March 19 after being cleared by the FCC and Justice Department, yet the deal isn't free from risk due to lawsuits to unwind it by eight states and DirecTV.
-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in the biotech sector. Pfizer said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, a lackluster result as fewer-than-expected infections in the pivotal study made its potency hard to evaluate.
See omnystudio.com/listener for privacy information.
